BibTex format
@article{Efron:2024:10.1080/21645515.2024.2378537,
author = {Efron, A and Brozzi, A and Biolchi, A and Bodini, M and Giuliani, M and Guidotti, S and Lorenzo, F and Moscoloni, MA and Muzzi, A and Nocita, F and Pizza, M and Rappuoli, R and Tomei, S and Vidal, G and Vizzotti, C and Campos, J and Sorhouet, Pereira C},
doi = {10.1080/21645515.2024.2378537},
journal = {Hum Vaccin Immunother},
title = {Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.},
url = {http://dx.doi.org/10.1080/21645515.2024.2378537},
volume = {20},
year = {2024}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - Meningococcal (Neisseria meningitidis) serogroup B (MenB) strain antigens are diverse and a limited number of strains can be evaluated using the human serum bactericidal antibody (hSBA) assay. The genetic Meningococcal Antigen Typing System (gMATS) was developed to predict the likelihood of coverage for large numbers of isolates by the 4CMenB vaccine, which includes antigens Neisseria adhesin A (NadA), Neisserial Heparin-Binding Antigen (NHBA), factor H-binding protein (fHbp), and Porin A (PorA). In this study, we characterized by whole-genome analyses 284 invasive MenB isolates collected from 2010 to 2014 by the Argentinian National Laboratories Network (52-61 isolates per year). Strain coverage was estimated by gMATS on all isolates and by hSBA assay on 74 randomly selected isolates, representative of the whole panel. The four most common clonal complexes (CCs), accounting for 81.3% of isolates, were CC-865 (75 isolates, 26.4%), CC-32 (59, 20.8%), CC-35 (59, 20.8%), and CC-41/44 (38, 13.4%). Vaccine antigen genotyping showed diversity. The most prevalent variants/peptides were fHbp variant 2, NHBA peptides 24, 21, and 2, and PorA variable region 2 profiles 16-36 and 14. The nadA gene was present in 66 (23.2%) isolates. Estimated strain coverage by hSBA assay showed 78.4% of isolates were killed by pooled adolescent sera, and 51.4% and 64.9% (based on two different thresholds) were killed by pooled infant sera. Estimated coverage by gMATS (61.3%; prediction interval: 55.5%, 66.7%) was consistent with the infant hSBA assay results. Continued genomic surveillance is needed to evaluate the persistence of major MenB CCs in Argentina.
AU - Efron,A
AU - Brozzi,A
AU - Biolchi,A
AU - Bodini,M
AU - Giuliani,M
AU - Guidotti,S
AU - Lorenzo,F
AU - Moscoloni,MA
AU - Muzzi,A
AU - Nocita,F
AU - Pizza,M
AU - Rappuoli,R
AU - Tomei,S
AU - Vidal,G
AU - Vizzotti,C
AU - Campos,J
AU - Sorhouet,Pereira C
DO - 10.1080/21645515.2024.2378537
PY - 2024///
TI - Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.
T2 - Hum Vaccin Immunother
UR - http://dx.doi.org/10.1080/21645515.2024.2378537
UR - https://www.ncbi.nlm.nih.gov/pubmed/39037011
VL - 20
ER -